Augmented Nurse Care Management in CKD Stages 4 to 5: A Randomized Trial Steven Fishbane, MD, Sofia Agoritsas, MPA, Alessandro Bellucci, MD, Candice Halinski, MSN, NP-C, Hitesh H. Shah, MD, Vipul Sakhiya, MPH, Leah Balsam, MD American Journal of Kidney Diseases Volume 70, Issue 4, Pages 498-505 (October 2017) DOI: 10.1053/j.ajkd.2017.02.366 Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Patient flow diagram. Abbreviation: HT, Healthy Transitions in Late Stage Kidney Disease program (intervention). American Journal of Kidney Diseases 2017 70, 498-505DOI: (10.1053/j.ajkd.2017.02.366) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions
Figure 2 Display of cumulative end-stage kidney disease starts over time by the 2 study groups. The black line indicates the intervention group; the grey line, controls. Abbreviation: HT, Healthy Transitions in Late Stage Kidney Disease program (intervention). American Journal of Kidney Diseases 2017 70, 498-505DOI: (10.1053/j.ajkd.2017.02.366) Copyright © 2017 National Kidney Foundation, Inc. Terms and Conditions